300253 Winning Health Technology Group
- 7.03
- +0.09+1.30%
Winning Health Technology Group News
Weining Health (300253.SZ): Net profit of 166.204 million yuan for the first quarter reversed year-on-year losses
On April 26, Ge Longhui Health (300253.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 494 million yuan, up 10.09% year on year; net profit attributable to shareholders of listed companies was 166.204 million yuan, turning a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 8.6877 million yuan; basic earnings per share were 0.0077 yuan.
Winning Health Technology Group (SZSE:300253) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Winning Health Technology Group Co., Ltd. (SZSE:300253) announced strong profits, but the stock was stagnant. We did some digging, and we found some concerning factors in the details. SZSE:300253
Winning Health Technology Group Co., Ltd. Just Missed Revenue By 5.6%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Winning Health Technology Group Co., Ltd. (SZSE:300253), which a week ago released some disappointing full-year results that could have a notable impact on how
Weining Health (300253.SZ): 2023 net profit of 358 million yuan, plans to distribute 10 to 0.2 yuan
Gelonghui, April 18 | Weining Health (300253.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 3.163 billion yuan, an increase of 2.28%; net profit attributable to shareholders of listed companies was 358 million yuan, an increase of 229.49%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 333 million yuan, an increase of 178.51% year on year; basic income per share was 0.1667 yuan; it plans to distribute a cash dividend of 0.20 yuan (tax included) to all shareholders for every 10 shares.
Investors Three-year Losses Continue as Winning Health Technology Group (SZSE:300253) Dips a Further 6.1% This Week, Earnings Continue to Decline
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Winning Health Technology Group Co., Ltd. (SZSE:300253) shareholders know that all too well, since the s
Be Wary Of Winning Health Technology Group (SZSE:300253) And Its Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Ideally, a business will show two trends; firstly a growing retur
Weining Health (300253.SZ): Weining Health's self-developed medical model WingPT does not currently use KIMI-related technology
Gelonghui, March 21丨An investor asked Wei Ning Health (300253.SZ) on the investor interactive platform, “Does the company's self-developed WingPT use KIMI-related technology? Do the latest versions of WingPT 3.0 and KIMI have unique advantages in the field of medical information services?” The company replied that Weining Health's self-developed medical model WingPT is currently not using KIMI-related technology. The company will continue to invest in the development of WinGPT's own technology.
Winning Health Technology Group Co., Ltd.'s (SZSE:300253) Shares Bounce 30% But Its Business Still Trails The Industry
Those holding Winning Health Technology Group Co., Ltd. (SZSE:300253) shares would be relieved that the share price has rebounded 30% in the last thirty days, but it needs to keep going to repair the
Winning Health Technology Group Co., Ltd.'s (SZSE:300253) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Most readers would already be aware that Winning Health Technology Group's (SZSE:300253) stock increased significantly by 19% over the past month. However, we decided to pay attention to the company
Weining Health (300253.SZ): The company established a forward-looking artificial intelligence laboratory in 2017, and has invested and prepared for many years
On February 22, Ge Longhui | Wei Ning Health (300253.SZ) said during a survey of specific subjects that the key to the application of medical AI is that the model must be integrated with the medical scenario, which is not the same as the general model. The company established a forward-looking artificial intelligence laboratory in 2017, and has invested and prepared for many years. We believe that future implementation and output will mainly depend on the maturity of the downstream market.
Weining Health (300253.SZ): Overall repayment (excluding key) increased by more than 10% year-on-year in 2023
On February 22, Ge Longhui | Weining Health (300253.SZ) said during a survey by specific targets that overall repayments (excluding keys) increased by more than 10% year-on-year in 2023. Among them, repayments for long-term accounts were better than repayments under new contracts. Strengthening accounts receivable collection in 2024 is still one of the key tasks. The main measures include strong supervision (controlling each collection node), increasing incentives (such as focusing on frontline employees), and increasing the project closure rate.
Weining Health (300253.SZ): WineX series products delivered to more than 200 hospitals in 2023
On February 22, Ge Longhui | Weining Health (300253.SZ) said during a survey of specific subjects that in 2023, WineX series products were delivered to more than 200 hospitals, including overall delivery projects for major clinical trials, to more than 20 hospitals. The positive impact of normalized promotion on the implementation cycle and cost side will be gradual. It is a climbing process. 2023 will be affected by the external environment. Normalized promotion is later than expected, and mass delivery is expected to begin in 2024. Key projects such as Peking University People's Hospital have received good reviews in the industry and customers as benchmark projects for the overall delivery of WineX, promoting the business
Galaxy Securities: The 2024 big model application will enter the implementation period and I am optimistic about the commercial development of AIGC
The Zhitong Finance App learned that Galaxy Securities released a research report saying that recently, the fourth batch of large domestic models passed the filing. A total of 13 companies and 14 large domestic models were included in this batch. The bank believes that big model applications will enter the implementation period in 2024. On the one hand, the commercial application of large models in vertical fields is accelerating, and on the other hand, multi-modal large models are emerging, and application scenarios will be even richer. The bank is optimistic about the commercial development of AIGC. It is recommended to pay attention to: iFLYTEK (002230.SZ), Jinshan Office (688111.SH), Tonghuashun (300033.SZ), Fluorite Network (688)
Weining Health (300253.SZ): “Test Case Execution Result Analysis Method, Device, Equipment and Storage Medium” obtained an invention patent
Gelonghui, January 31,丨Weining Health (300253.SZ) announced that the company recently obtained an invention patent certificate issued by the State Intellectual Property Office. It is a method, device, equipment and storage medium for analyzing test case execution results.
Retail Investors Who Own 46% Along With Institutions Invested in Winning Health Technology Group Co., Ltd. (SZSE:300253) Saw Increase in Their Holdings Value Last Week
Key Insights The considerable ownership by retail investors in Winning Health Technology Group indicates that they collectively have a greater say in management and business strategy A total of 18 i
Weining Health (300253.SZ): Net profit is expected to rise 223.69%-319.6% year on year in 2023
Gelonghui, January 29丨Weining Health (300253.SZ) announced that net profit is expected to be 351 million yuan to 455 million yuan in 2023, up 223.69%-319.6% from the same period last year, after deducting non-net profit of 30,8 million yuan - 412 million yuan, an increase of 158.37% to 245.62% over the same period last year. In 2023, in the face of a complex and severe external environment, the company will continue to promote the coordinated development of “X” digital health application scenarios using WinEX series products as “1” and “X” digital health application scenarios such as Internet hospitals and medical insurance linkages to create a comprehensive range of services for customers
Weining Health (300253.SZ): It currently has user resources for more than 6,000 medical and health institutions
Gelonghui January 16 丨 Some investors asked Weining Health (300253.SZ) on the investor interactive platform, “Does the company's AI+ Healthcare have user resources? “What are the future development plans,” the company replied. Regarding the combined application of AI and medical care, the company currently has user resources in more than 6,000 medical and health institutions, and the number of users will expand further in the future. For future development plans related to AI, please pay attention to the relevant content in the company's regular report “Section 3 Management Discussion and Analysis”.
Weining Health (300253.SZ): As of December 29, 2023, the number of shareholders of the company was 77,467
Gelonghui, January 9 | Weining Health (300253.SZ) said on the investor interactive platform that according to the latest data issued by China Settlement Shenzhen Branch, as of December 29, 2023, the number of shareholders of the company was 77,467. In addition, as previously answered, the number of shareholders of the company as of November 30, 2023 was 76,450.
These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Weining Health (300253.SZ): “A medical data retrieval method, device, equipment and storage medium” obtained an invention patent
Gelonghui, December 27丨Weining Health (300253.SZ) announced that the company recently obtained an invention patent certificate issued by the State Intellectual Property Office. It is a medical data retrieval method, device, equipment, and storage medium.
Analysis
Price Target
No Data
